URO TODAY: Docetaxel plus estramustine chemotherapy represents an active and well-tolerated treatment for Japanese hormone-refractory prostate cancer patients. READ MORE>
Posts Tagged ‘docetaxel’
New chemo drugs work well for hormone-resistant prostate cancer patients
Posted in Chemotherapy, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged advanced prostate cancer, cancer research, Chemotherapy, docetaxel, estramustine, hormone-refractory, Japanese hormone-refractory prostate cancer patients, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, URO TODAY, well-tolerated treatment on August 20, 2009 | Leave a Comment »
PROSTATE RESEARCH: Study looks at management of castration-resistant patients
Posted in Hormone therapy, Hormone-refactory, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged advanced prostate cancer, cancer research, castration-resistant prostate cancer, docetaxel, Hormone therapy, paclitaxel-based chemotherapy, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate on June 24, 2009 | Leave a Comment »
JUNE 24: URO TODAY: Management of castration-resistant prostate cancer after docetaxel has become an unmet need for which various agents have been investigated. READ MORE>









